Profitability
2.2%
1st of 4 listed peers · median of the other 3: −2.3%
Net margin 0.0% (FY25)
return on capital
2.2%0.7%−2.3%−60.2%
Gian Life CareASHRAM ONLINE.COMTRANSGENE BIOTEKFAMILY CARE HOSPITALS
Median of the other 3: −2.3%
BSE: GIANLIFE · Healthcare · Healthcare Service Provider · Market cap ₹4 Cr
· Prev close ₹4.32 · Volume 543 · 52W ₹4–13
Company profile: not in our data yet
Net margin 0.0% (FY25)
Median of the other 3: −2.3%
Generated Return on capital is 2.2%, 1st of 4 listed peers.
Profit, last 4 quarters vs the 4 before: not in our data yet
P/E not shown: the latest four quarters in our data end Dec 2025, more than six months ago
Of profit came in as cash, last 5 fiscal years: not in our data yet
Generated Operating cash was positive in FY25. Total debt was ₹6 cr at the end of FY25, against a net worth of ₹19 cr.
Held by domestic funds: not in our data yet
1Y return −66.0%
Generated The 52-week range runs from ₹3.93 to ₹13.20; the 12 Nov close of ₹4.32 sits 4% of the way up. Over 1 year it is down 66.0%.
An earnings call transcript: not in our data yet
Scored statements from the earnings calls: none yet.
Earnings outlook Generated
In Q3 FY26 (Dec 25), net profit was −71.3% on the year-earlier quarter; operating margin was 29.8% against 39.9%.
An earnings call transcript: not in our data yet